Immunoglobulin National Society Convenes 15th Annual Conference in Las Vegas

LAS VEGAS, Oct. 15, 2026 /CourierPR/ -- The Immunoglobulin National Society (IgNS) has convened its 15th annual national conference in Las Vegas, bringing together more than 1,500 attendees from over 500 companies. The event, held at the Red Rock Casino Resort & Spa from October 15 to 18, aims to advance the field of immunoglobulin therapy and biologics through education, collaboration, and networking.

This year's conference features over 50 clinical and business sessions, offering more than 30 continuing education (CE/CME) and recertification units. The program is designed to address the complex issues shaping the industry, including new therapies and indications, evolving sites of care, and ongoing industry challenges.

Seminars and specialized educational tracks are available for clinical, operational, and business leaders, ensuring a comprehensive approach to the latest developments. Practice-focused programming will tackle key issues in care delivery, business operations, and the regulatory landscape, providing valuable insights for professionals in the field.

Networking opportunities are abundant, allowing attendees to build professional connections and foster collaboration. The Expo Hall will showcase leading companies and industry partners, offering therapies, resources, services, and solutions to attendees.

Luba Sobolevsky, PharmD, IgCP®, President and CEO of IgNS, expressed excitement about the milestone event.

Amy Clarke, DNP, RN, IgCN®, Chief Clinical Officer of IgNS, highlighted the importance of the conference in light of the industry's evolving landscape.

The conference provides a platform for industry leaders to come together and address the challenges and opportunities facing the immunoglobulin and biologics sector. With a focus on education, collaboration, and innovation, the event is expected to drive significant advancements in the field.